Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Malgorzata

Malgorzata Adamowska, Gliwice PL

Patent application numberDescriptionPublished
20120027653CATALYTIC COMPOSITION FOR TREATING COAL COMBUSTION GASES, METHOD FOR PREPARING SAME, CATALYTIC SYSTEM INCLUDING SAME, AND USE THEREOF - The invention relates to a catalytic composition for treating coal combustion gases, to a method for preparing said composition, to a catalytic system having such a composition, and to the use of the catalytic composition for treating coal combustion gases. The catalytic composition is made of particles of a solid composition cCeO02-02-2012

Malgorzata Beryt, Malibu, CA US

Patent application numberDescriptionPublished
20100055093PAN-CELL SURFACE RECEPTOR-SPECIFIC THERAPEUTICS - Provided are pan-cell surface receptor-specific therapeutics, methods for preparing them and methods of treatment using them. Among the pan-cell surface receptor-specific therapeutics are pan-HER-specific therapeutics that interact with at least two different HER receptor ligands and/or dimerize with or interact with two or more HER cell surface receptors. By virtue of these properties, the therapeutics modulate the activity of at least two cell surface receptors and are useful for therapeutic purposes.03-04-2010

Malgorzata Borowiak, Somerville, MA US

Patent application numberDescriptionPublished
20110070645COMPOSITIONS AND METHODS FOR PROMOTING THE GENERATION OF PDX1+ PANCREATIC CELLS - Certain embodiments disclosed herein are directed to a method of producing pancreatic cells or pancreatic cell precursors by exposing human embryonic stem cells to an effective amount of at least one compound listed in Table I to differentiate the human embryonic stem cells into the pancreatic cells or the pancreatic cell precursors. Kits and pancreatic cell lines produced using the methods are also described.03-24-2011

Malgorzata Hanulak, Birmingham, MI US

Patent application numberDescriptionPublished
20110070566Meal Planning System - A meal planning system may include first, second and third grocery lists, a plurality of first recipes and a plurality of second recipes. The second grocery list may be associated with the first grocery list. The first recipes may be associated with the second grocery list. Each of the first recipes may include food items from at least one of the first and second grocery lists. The second grocery list includes enough food items to prepare the first recipes. The third grocery list may be associated with the first grocery list. The second recipes may be associated with the third grocery list. Each of the second recipes may include food items from at least one of the first and third grocery lists. The third grocery list includes enough food items to prepare the second recipes. The grocery lists and recipes may be displayed on cards and/or an electronic device.03-24-2011

Malgorzata Jurczak, Leuven BE

Patent application numberDescriptionPublished
20110317486Methods for Operating a Semiconductor Device - Multi-gate metal-oxide-semiconductor (MOS) transistors and methods of operating such multi-gate MOS transistors are disclosed. In one embodiment, the multi-gate MOS transistor comprises a first gate associated with a first body factor and comprising a first gate electrode for applying a first gate voltage, and a second gate associated with a second body factor greater than or equal to the first body factor and comprising a second gate electrode for applying a second gate voltage. The multi-gate MOS transistor further comprises a body of semiconductor material between the first dielectric layer and the second dielectric layer, where the semiconductor body comprises a first channel region located close to the first dielectric layer and a second channel region located close to the second dielectric layer. The multi-gate MOS transistor still further comprises a source region and a drain region each having a conductivity type different from a conductivity type of the body.12-29-2011

Malgorzata Kesik, Warszawa PL

Patent application numberDescriptionPublished
20100297773EXPRESSION CASSETTE, USE OF THE EXPRESSION CASSETTE, VECTOR, HOST CELL, A METHOD FOR PRODUCING A POLYPEPTIDE - The subject matters of invention relate to expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide ensuring its stable expression by the prokaryotic host as well as an use of the expression cassette. The invention enables stable expression of the target polypeptide, in systems where DNA-dependent RNA polymerase recognises promoter regulating synthesis of target protein as well as selection marker, which is required for survival of the host.11-25-2010

Malgorzata Kesik-Brodacka, Warszawa PL

Patent application numberDescriptionPublished
20110136736NEW INSULIN ANALOGUES OF PROLONGED ACTIVITY - New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes.06-09-2011

Malgorzata Kloczko, Neustadt/wied DE

Patent application numberDescriptionPublished
20100158965WINDOW STICKER FOR ATTRACTING AND DESTROYING INSECTS - There is disclosed a product for attracting and destroying insects which comprises an active-substance-comprising bait layer (1) together with a bait substance and an insecticide. The active-substance-comprising bait layer (1) furthermore comprises a superdisintegrant whose effect is that, upon the use of the product in an environment with high atmospheric humidity, the active-substance-comprising bait layer (1) does not run.06-24-2010
20100260820PLASTER FOR PLANTS WITH AN EXPANDED MATRIX - The invention relates to a plaster for applying systemic active substances to plants, the matrix thereof, that contains the active substance, is expanded and consists of in particular, a hot melt adhesive containing the active substance. Said plaster, based on its flexibility and adhesiveness, is suitable for applying active substances to the trunk or branches of trees.10-14-2010

Patent applications by Malgorzata Kloczko, Neustadt/wied DE

Malgorzata Klukowska, Mason, OH US

Patent application numberDescriptionPublished
20110104080Oral Compositions for Treatment of Dry Mouth - An oral care composition for the treatment of dry mouth comprising a polyethylene oxide with a molecular weight from about 200,000 to about 7,000,000, an anti-bacterial agent, and a sensate.05-05-2011

Malgorzata Kotnowska US

Patent application numberDescriptionPublished
20100276322ICE MASSAGE DEVICE - The subject of the invention is an ice massage device for body care and rehabilitative purposes. The ice massage device comprising a container [1], the container lid [3], the lid handle [5] and an element [4] fixing ice to the lid is characterised in that the lid [3], the lid handle [5] and the ice-fixing element [4] make one whole, while in the bottom of the uniform, open-at-the-top container [1] there is a cavity [2] in the shape of a cone directed towards the inside of the container.11-04-2010

Malgorzata Lipowska, Decatur, GA US

Patent application numberDescriptionPublished
20110064656Methods of Determining Renal Function using Technetium-99m Tricarbonyl-nitrilotriacetic acid - This disclosure relates to the methods of imaging the kidneys and measuring renal function using the renal tracer 03-17-2011

Malgorzata Lukawska, Warszawa PL

Patent application numberDescriptionPublished
20090298786METHODS OF TREATING VIRAL INFECTIONS WITH ANTHRACYCLINE ANTIBIOTICS - A method of treating hepatitis C viral infection or viremia in a patient by administering to the patient an anti-hepatitis C virally effective amount of a compound of Formula 1 or Formula 2. A method for inhibiting the replication of hepatitis C virus by exposing the virus to a hepatitis C viral NS3 protease inhibiting amount of: a compound of Formula 1 or Formula 2. A pharmaceutical composition exhibiting an antihelicase activity containing at least a pharmaceutically-acceptable carrier, diluent or excipient, and a compound of Formula 1 or Formula 2. The pharmaceutical composition may additionally contain a second compound of Formula 1 or Formula 2; epidoxorubicin, doxorubicin, epidaunorubicin, or daunorubicin; and/or another antiviral agent.12-03-2009

Malgorzata Myslinska, Los Angeles, CA US

Patent application numberDescriptionPublished
20090247766Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof - The invention relates to a nitrogen heterocycle compound of formula 1:10-01-2009
20110098483Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof - The invention relates to a nitrogen heterocycle compound of formula 1:04-28-2011

Malgorzata Rillich, Darmstadt DE

Patent application numberDescriptionPublished
20110051049LIQUID-CRYSTAL DISPLAY - The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (polymer-stabilised) and PSA (polymer-sustained alignment) type.03-03-2011
20110205482LIQUID-CRYSTAL DISPLAY - The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (polymer stabilised) or PSA (polymer sustained alignment) type.08-25-2011
20110233466LIQUID-CRYSTALLINE COMPOUNDS AND LIQUID-CRYSTALLINE MEDIA - The present invention relates to liquid-crystalline compounds having at least three fluorine-substituted benzene rings, a terminal trifluoromethyl group and at least one —CF09-29-2011
20110253935LIQUID-CRYSTALLINE COMPOUNDS AND LIQUID-CRYSTALLINE MEDIA - The present invention relates to liquid-crystalline compounds having two fluorinated biphenyl units, a terminal trifluoromethyl or trifluoromethoxy group and a —CF10-20-2011

Malgorzata Rosol, Barcelona ES

Patent application numberDescriptionPublished
20100240656COMPOUNDS AS HSP90 INHIBITORS - The invention provides novel compounds of formula (I) wherein: one of the a, b, c or d members is a nitrogen atom and the remaining members are carbon atoms; and R09-23-2010

Malgorzata Shteyngarts, Solon, OH US

Patent application numberDescriptionPublished
20090172023DATA MANAGEMENT SYSTEM FOR MANUFACTURING ENTERPRISE AND RELATED METHODS - A method, system, and interface for managing data in a manufacturing enterprise that provides a visual indication of projected results of currant activities. Method includes collecting multi-dimensional data comprising planned values and dynamically updated actual values, processing the values, projecting future events based on records of present and past events and comparison between the planned values and the processed actual values, and displaying an extrapolated status report indicating discrepancies between the planned values and the actual values. The system includes the interface comprising dynamically updated two-dimensional graphic display, a first dimension attribute corresponding to a preset interval of first dimension value from a present first dimension value onward, an array of second dimension attributes, sets of feature attributes that are associated with the second dimension attributes and presented as data in graphic or alphanumeric forms. The sets are located substantially within boundaries of the second dimension attributes.07-02-2009

Malgorzata Slupska, San Diego, CA US

Patent application numberDescriptionPublished
20100047392Enzymes Having Alpha Amylase Activity and Methods of Making and Using Them - The invention relates to alpha amylases and to polynucleotides and polypeptides encoding the alpha amylases. In addition, methods of using the alpha amylases are also provided. The alpha amylases have increased activity and stability at acidic, neutral and alkaline pH and at increased temperatures.02-25-2010
20110039308AMYLASES AND GLUCOAMYLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - In one aspect, the invention is directed to polypeptides having an amylase and/or glucoamylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. In one aspect, the polypeptides of the invention can be used as amylases, for example, alpha amylases, to catalyze the hydrolysis of polysaccharide, oligosaccharide or starch into sugars. In one aspect, the invention provides delayed release compositions comprising an desired ingredient coated by a latex polymer coating. In alternative embodiments, enzymes are used to make biofuels, e.g., ethanol, butanol, propanol, or a gasoline-ethanol mix, including a bioethanol, biopropanol, biobutanol, or a biodiesel, or for any form of fuel or biomass processing.02-17-2011
20110171693AMYLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. In one aspect, the polypeptides of the invention can be used as amylases, for example, alpha amylases, to catalyze the hydrolysis of starch into sugars. In one aspect, the invention provides delayed release compositions comprising an desired ingredient coated by a latex polymer coating.07-14-2011

Patent applications by Malgorzata Slupska, San Diego, CA US

Malgorzata Szymczyk, Raleigh, NC US

Patent application numberDescriptionPublished
20080216256Heterobifunctional reactive dyes comprising a cysteamine linking group - The presently disclosed subject matter relates to heterobifunctional reactive dyes comprising nitrogen-containing heterocycles substituted by both halogen and vinyl sulfone moieties. In particular, the presently disclosed subject matter relates to reactive dye compounds comprising two or more halo-substituted, nitrogen-containing heterocycles and an asymmetric bridging group, wherein at least one of the two or more halo-substituted, nitrogen-containing heterocycles further comprises a vinyl sulfone substituent. In some embodiments, the bridging group has a structure based on cysteamine or cysteine. The heterobifunctional reactive dyes have high substrate affinity and can be applied to substrates, such as cotton fibers, under low salt conditions and with reduced dye material waste.09-11-2008

Malgorzata Tomala, Nowe Miasto Nad Pilica PL

Patent application numberDescriptionPublished
20110276838Logged Drive Test Reporting - A network receives from a user equipment UE information about a measurement configuration used to log test measurements; and the network uses the received information to determine further signaling to send to the UE concerning further test measurements. The network can compare the received measurement configuration to a measurement configuration for the further test measurements; and if the same can merely indicate to the UE to continue using the same configuration else if different can indicate to the UE the new configuration to use for the further measurements. The UE logs the test measurements taken in the IDLE mode. After exiting the IDLE mode it sends to the network with which it connects information about the measurement configuration used to collect the measurements. The information can be sent in a RRC Connection Setup Complete message along with an availability indictor that the logged test measurements are available.11-10-2011

Malgorzata Wenska, Uppsala SE

Patent application numberDescriptionPublished
20110306138COMPLEX AND METHOD FOR ENHANCING NUCLEAR DELIVERY - The use of at least one nucleic acid based nuclear localization signal including a natural or synthetic m12-15-2011

Malgorzata Wilinska, Cambridge GB

Patent application numberDescriptionPublished
20100317952METHODS FOR REDUCING FALSE HYPOGLYCEMIA ALARM OCCURRENCE - A system and method for reducing the number of hypoglycemic alarms presented to a user is presented. The system and methods include use of model based state estimation and variable-delayed threshold values to balance the risk of not presenting an alarm caused by an actual hypoglycemic state with the presentation of alarms caused by artifacts in the signals produced by a continuous glucose monitor.12-16-2010